RTW Investments’s Ventyx Biosciences VTYX Stock Holding History

RTW Investments’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,388,881	Closed	-$46.5M	–	68
2023 Q1	$46.5M	Sell	1,388,881 -162,897	-10%	-$6.33M	0.97%	27
2022 Q4	$50.9M	Hold	1,551,778	–	–	1.04%	24
2022 Q3	$54.2M	Hold	1,551,778	–	–	1.25%	26
2022 Q2	$19M	Hold	1,551,778	–	–	0.49%	45
2022 Q1	$21.1M	Hold	1,551,778	–	–	0.44%	52
2021 Q4	$30.8M	Buy	+1,551,778	New	+$29.4M	0.45%	55

Other funds holding VTYX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

RTW Investments's VTYX Position: Q2 2023 in Review

RTW Investments sold out of Ventyx Biosciences (VTYX) in Q2 2023, closing a stake of 1,388,881 shares — an estimated $46.5M sold.

RTW Investments first reported a position in VTYX in Q4 2021 and held it in 6 quarters. The position peaked at $54.2M in Q3 2022. 150 funds tracked by Wall St. Rank hold VTYX as of Q2 2023.

RTW Investments reported no remaining Ventyx Biosciences position as of Q2 2023 after selling out during the quarter.
RTW Investments sold 1,388,881 Ventyx Biosciences shares in Q2 2023, an estimated $46.5M.
RTW Investments first reported a position in Ventyx Biosciences in Q4 2021 and held it in 6 quarters.
RTW Investments's Ventyx Biosciences position peaked at $54.2M in Q3 2022.
150 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2023.

Based on RTW Investments's 13F filing for Q2 2023, filed 14 Aug 2023.